PANCREATIC DUCTAL ADENOCARCINOMA
Clinical trials for PANCREATIC DUCTAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new PANCREATIC DUCTAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for PANCREATIC DUCTAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Novartis halts early trial of targeted radiation drug for tough cancers
Disease control TerminatedThis was an early-stage study to test the safety and find the right dose of a new radioactive drug called 177Lu-FF58 for people with advanced pancreatic, stomach, or brain cancer. The drug is designed to deliver radiation directly to tumors. The study was terminated early, and it…
Matched conditions: PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Apr 04, 2026 02:20 UTC
-
New drug trial halted early for advanced cancers
Disease control TerminatedThis early-stage trial tested an experimental drug called DCC-3084, both alone and combined with other cancer therapies, in people with advanced solid tumors driven by specific genetic mutations. The study aimed to find a safe dose and see if the drug could shrink tumors. It was …
Matched conditions: PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Deciphera Pharmaceuticals, LLC • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Aggressive surgery trial for advanced pancreatic cancer halted early
Disease control TerminatedThis study tested whether surgically removing both the main pancreatic tumor and a small number of tumors that had spread to the liver or lungs could help patients live longer. Participants first received standard chemotherapy. If their cancer did not worsen, they underwent major…
Matched conditions: PANCREATIC DUCTAL ADENOCARCINOMA
Phase: NA • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
First human test of experimental pancreatic cancer drug halted early
Disease control TerminatedThis was an early safety study to find the highest tolerable dose of a new drug called BI 765883 for adults with advanced pancreatic cancer. Participants received the drug either alone or combined with standard chemotherapy. The main goals were to check for side effects and see i…
Matched conditions: PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Two-Pronged attack tested for tough cancers
Disease control TerminatedThis study tested whether combining two drugs, niraparib and dostarlimab, could help control advanced cancers that had specific genetic problems or were previously sensitive to platinum chemotherapy. It involved 51 adults with various cancers, including bladder, stomach, and kidn…
Matched conditions: PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Targeted cancer drug trial halted after testing in 19 patients
Disease control TerminatedThis study tested an experimental drug called Promitil for people with advanced ovarian or pancreatic cancer that had specific genetic mutations and had worsened after initial treatment. The trial aimed to see if this new formulation could better control cancer growth while being…
Matched conditions: PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Lipomedix Pharmaceuticals Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
New imaging tracer tested to light up Hard-to-See cancers
Diagnosis TerminatedThis early-stage study tested a new imaging agent called [68Ga]-FF58. The goal was to see if this tracer could effectively highlight specific aggressive cancers—including brain, stomach, and pancreatic tumors—during a PET scan. A small group of adult patients with these cancers r…
Matched conditions: PANCREATIC DUCTAL ADENOCARCINOMA
Phase: EARLY_PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Diagnosis
Last updated Apr 03, 2026 14:43 UTC
-
Could a common antidepressant help people battling pancreatic cancer?
Symptom relief TerminatedThis study tested if the antidepressant escitalopram could prevent depression and improve quality of life in people with localized pancreatic or related cancers. Participants were receiving chemotherapy before possible surgery and were not already on psychiatric medications. The …
Matched conditions: PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Case Comprehensive Cancer Center • Aim: Symptom relief
Last updated Mar 30, 2026 14:29 UTC